Postmenopausal unopposed estrogens characteristics of use in relation to the risk of endometrial carcinoma
- 31 May 1993
- journal article
- research article
- Published by Elsevier in Annals of Epidemiology
- Vol. 3 (3), 308-318
- https://doi.org/10.1016/1047-2797(93)90035-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Progestagen supplementation of exogenous oestrogens and risk of endometrial cancerThe Lancet, 1991
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.BMJ, 1989
- The role of oestrogens and progestagens in the epidemiology and prevention of breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Prevention of endometrial cancer with progestogensMaturitas, 1986
- “ALTERNATIVE” CONTROLS IN A CASE-CONTROL STUDY OF ENDOMETRIAL CANCER AND EXOGENOUS ESTROGENAmerican Journal of Epidemiology, 1980
- A case-control study of menopausal estrogen therapy and breast cancerJAMA, 1980
- Estrogen use — Risk of endometrial carcinomaGynecologic Oncology, 1978